Researchers developed PEA-Risk, a 12-variable clinical algorithm that predicts pulseless electrical activity sudden cardiac arrest (PEA-SCA) with 86% accuracy in training data and 70% accuracy in external validation across nearly 2 million people. The model incorporates clinical history, ECG findings, and medications to identify high-risk patients before this typically fatal form of cardiac arrest occurs. This represents a significant advance in preventive cardiology, as PEA accounts for an increasing proportion of sudden cardiac deaths with survival rates below 5%. Unlike ventricular fibrillation, PEA rarely responds to defibrillation, making prevention the only viable strategy. The algorithm could enable targeted interventions like enhanced monitoring, medication optimization, or device therapy for vulnerable patients. However, this preprint awaits peer review, and the clinical variables comprising the model aren't fully detailed. The drop in accuracy from internal to external validation suggests geographic or population-specific factors may limit generalizability. While promising for risk stratification, prospective studies must demonstrate whether acting on these predictions actually prevents PEA events and improves outcomes.